Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

* Male and female patients, age ≥ 12. * Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI\<50) with or without facial involvement. * Medical history available within the last 6 months. * Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and \< 18 years of age at inclusion visit). * Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable.

* Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection. * Segmental or localized vitiligo. * Greater than 33% leukotrichia in areas of vitiligo on the face or on the body. * History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo. * Patients who are participating in interventional clinical trial(s) at time of study visit. * Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment.